Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory bug.

The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...

WASHINGTON — President Trump’s major domestic policy law will result in nearly 10 million more people going without health ...

CASP, the protein structure prediction contest that launched DeepMind’s Alphafold to international fame and a Nobel Prize, ...

AstraZeneca announced that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

University of Minnesota president Rebecca Cunningham is drawing on her experience as an emergency physician in this ...

Omega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly $650 million to invest in ...

As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...